Study of Intravenous Magnesium Sulfate Compared to Dexketoprofen for Treating Acute Dysmenorrhea in Women Aged 18 to 35

What this Trial Is About

This clinical trial investigates the pain relief effects of intravenous magnesium sulfate in women aged 18 to 35 years who come to the emergency department with acute primary dysmenorrhea. The study compares magnesium sulfate to dexketoprofen, a standard nonsteroidal anti-inflammatory drug, to see which provides better pain control. Participants have regular menstrual cycles and experience significant pain, as measured by a pain scale. Participants are randomly assigned to receive either 2 ampoules of magnesium sulfate or 50 mg of dexketoprofen, both diluted in 100 ml of normal saline and given intravenously over 15 minutes. Pain levels will be measured before treatment and one hour after administration using the Visual Analog Scale VAS. The study also monitors patient satisfaction, vital signs, and possible side effects. During the study, participants will be assessed at admission and one hour after treatment to evaluate changes in pain intensity. Researchers will track vital signs and any adverse events. The total participation involves these assessments in the emergency setting, focusing on the immediate response to treatment for acute dysmenorrhea.

IV Magnesium in the Treatment of Acute Dysmenorrhea